Medical/Pharmaceuticals

Antengene Announces Claudin 18.2 Antibody-Drug Conjugate ATG-022 Granted Orphan Drug Designations by the U.S. FDA for the Treatment of Gastric and Pancreatic Cancers

SHANGHAI and HONG KONG, May 23, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hemato...

2023-05-23 17:25 2663

OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History

KYOTO, Japan, May 23, 2023 /PRNewswire/ -- OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in Muko City, Kyoto Prefecture, Japan, is proud to announce the celebration of its 50th anniversary in blood pressure monitor production this year. Since the introduction of its fi...

2023-05-23 14:00 2420

Chula Medicine Found Thai Herbal Tea Comparable to Modern Medicines in Stimulating Breast Milk Production

Chula Faculty of Medicine, in collaboration with the Department of Thai Traditional and Alternative Medicine, released research results on "Wang Nam Yen " herbal tea to stimulate lactation in mothers after childbirth, especially those who have had a cesarean delivery. The herbal tea yielded as goo...

2023-05-23 13:39 2864

CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech

MONROE, Ohio, May 22, 2023 /PRNewswire/ -- CSafe, the largest provider of a complete range of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, is honored to announce an innovative program forKrystal Biotech that provides the cold chain solution for Kry...

2023-05-22 21:23 3072

EBR Systems' Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results Lead to Early Trial Halt for Success

Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug Administration Approval and Commercialisation * The pivotal SOLVE-CRT study evaluated EBR Systems' WiSE® CRT System, the world's first and only wireless, inside t...

2023-05-22 21:00 2517

Proem Behavioral Health and Dr. David V. Sheehan Issue Joint Statement

ATLANTA, May 22, 2023 /PRNewswire/ -- Proem Behavioral Health and Dr. David Sheehan have issued the following joint statement: "Nview Health, Inc., now known as Proem Behavioral Health, has exclusive rights to all Sheehan Technology in digital, electronic and pdf versions, except that Dr. Sheeha...

2023-05-22 20:00 2132

A random placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

HONG KONG, May 22, 2023 /PRNewswire/ -- 70% of patients in Hong Kong who have recovered from COVID-19continue to suffer from at least one long COVID symptoms at around 6 months. There is however no proven treatment for long COVID. The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (C...

2023-05-22 16:37 3395

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS

FIRST-EVER PHASE III RANDOMIZED CONTROLLED TRIAL OF ATRIAL SHUNT THERAPY SHOWS CONTINUED PROMISE TEWKSBURY, Mass., May 22, 2023 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced two-year results from its REDUCE LAP-HF II rand...

2023-05-22 16:02 2174

TVM Capital Healthcare Announces Euro 10 Million Investment in DEBx Medical

DEBx Medical is innovating the management of chronic wounds, improving the life of millions of patients – the investment will enable the company to expand its global footprint and build a presence in the MENA region DUBAI, UAE and AMSTERDAM, May 22, 2023 /PRNewswire/ -- TVM Capital Healthcare, a...

2023-05-22 14:00 2709

1 in 10[1] people and 1 in 2 diabetics[2] suffer from Peripheral Neuropathy while 80% of patients remain undiagnosed[3]

Leading Global Health Experts converge at P&G's 'Demystifying Neuropathy Forum' to address the growing Public Health Concern of Peripheral Neuropathy MUMBAI, India, May 22, 2023 /PRNewswire/ -- As part of Neuropathy Awareness Week 2023, P&G Health, brought together globally renowned health expert...

2023-05-22 11:45 915

Oncoclínicas Group records a net revenue of BRL 41 million for Q123

The company reported 171 million for the last twelve months, with a 60% growth in net revenue and its best EBITDA ever SAO PAULO, May 22, 2023 /PRNewswire/ -- Oncoclínicas Group (ONCO3) - the largest group dedicated to cancer treatment inLatin America - announced its results for the first quarte...

2023-05-22 11:18 2776

One BioMed Announce World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction

Beyond Simple HMW DNA extraction at scale. SINGAPORE, May 22, 2023 /PRNewswire/ -- One BioMed, announced today the launch of the X8™ HMW DNA Cartridge Kits for the automated extraction of high molecular weight DNA for use in long-read sequencing and genome assembly. Inclusive of all the necessa...

2023-05-22 08:00 3053

Hisense HD60 Demonstrated in Clinical Training at University Hospital of Valdecilla in Spain

CAPE TOWN, South Africa, May 19, 2023 /PRNewswire/ -- Hisense, a manufacturer and provider of high-performance electronics and medical devices, recently participated atSpain's University Hospital of Valdecilla clinical ultrasound in traumatology training program as part of the company's effort of...

2023-05-19 19:37 1982

Another Hisense HD60 Ultrasound Installation at Vaal Radiology, South Africa

CAPE TOWN, South Africa, May 19, 2023 /PRNewswire/ -- Hisense, a manufacturer and provider of high-performance electronics and medical devices, has recently installed the Hisense Ultrasound HD60 at Vaal Radiology, a medical imaging center in Vereeninging,South Africa. This color Doppler ultrasoun...

2023-05-19 17:58 2006

Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey

The survey reveals 84% of Asia Pacific Consumers recognize the importance of a support group in helping them achieve health and wellness goals HONG KONG, May 19, 2023 /PRNewswire/ -- Herbalife, a premier health and wellness company and community, today released the findings of its Asia Pacific H...

2023-05-19 16:38 3260

Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial

SEOUL, South Korea, May 19, 2023 /PRNewswire/ -- Genome & Company (CEO: Pae, Jisoo), a global leading microbiome therapeutics developer, announced that this phase II trial (NCT05419362) will continue without modifications to move on to the second stage, based on the positive result of the interim...

2023-05-19 16:00 1960

EuroPCR 2023 | 6 Month Outcome of the SMART Study: satisfactory BP control achieved with reduced medication burden

PARIS, May 19, 2023 /PRNewswire/ -- On May 17th 2023, the six-month result of the SMART Study (Sympathetic Mapping/Ablation Renal nerves for Treatment of hypertension Trial; NCT02761811) was released on the Late Breaking Clinical Trial conference, reporting ground-breaking findings in the field o...

2023-05-19 14:54 1883

The Seventy-sixth World Health Assembly: Urgent global action to prioritise mental health

LONDON, May 19, 2023 /PRNewswire/ -- As WHO Member States, funders, health practitioners, civil society organisations and businesses engage at the Seventy-sixth World Health Assembly inGeneva, Switzerland from 21st – 30th May, under the theme "WHO at 75: Saving lives, driving health for all", the...

2023-05-19 06:00 2907

Endogenex™ Appoints Christopher Sorli as Chief Medical Officer

Bringing expertise in diabetes management, medical and regulatory affairs, clinical research, and market access MINNEAPOLIS, May 18, 2023 /PRNewswire/ -- Endogenex, Inc., a clinical stage medical device company, is proud to announce the addition ofChristopher Sorli, M.D., Ph.D., as Chief Medical...

2023-05-18 22:00 3142

The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China.

CHENGDU, China, May 18, 2023 /PRNewswire/ -- On May 17, 2023, Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (Sf9 cells) developed by WestVac Biopharma/ West China Medical Center,Sichuan University against the most recent cir...

2023-05-18 21:23 4497
1 ... 108109110111112113114 ... 397